| Trial registration number
|
IRCT20141209020258N165 |
Full text link
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
http://en.irct.ir/trial/58524
|
First author
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Dr Alireza Kamali
|
Contact
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
alikamaliir@yahoo.com
|
Registration date
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2021-09-10
|
Recruitment status
Last imported at : Sept. 23, 2022, 9:30 a.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Completed
|
Study design
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
RCT
|
Allocation
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Randomized
|
Design
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Parallel
|
Masking
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Blind label
|
Center
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
single-center
|
Study aim
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Treatment
|
Inclusion criteria
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Suffering Covid-19 without intubation
Apache less than 25
28 to 75 years
Absence of acute asthma
Absence of acute pulmonary hemorrhage
Absence of lung tumor
Absence of untreated pneumothorax
Do not take anticoagulants (coumadin group such as warfarin)
No history of kidney or liver disease
No diabetes (because of the risk of hypoglycemia)
No history of seizures
|
Exclusion criteria
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Death
Patient dissatisfaction with attending the study for any reason
|
Number of arms
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
2
|
Funding
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Arak University of Medical Sciences
|
Inclusion age min
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
28
|
Inclusion age max
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
75
|
Countries
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Iran
|
Type of patients
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Moderate/severe disease at enrollment
|
Severity scale
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
4: Moderate/severe disease at enrollment
|
Total sample size
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
64
|
primary outcome
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Intravenous blood gas samples
Disease severity
length of hospital stay
Mortality
|
Notes
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
|
Phase
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
Phase 3
|
Arms
Last imported at : Sept. 12, 2021, 12:27 p.m.
Source : Iranian Registry of Clinical Trials (IRCT)
|
[{"arm_notes": "", "treatment_id": 720, "treatment_name": "L-carnitine", "treatment_type": "Vitamins and dietary supplements", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]
|